未登录

S

Sara Harrysson

karolinska institutet

H指数:9

被引数:282

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Incidence, timing, and prognosis of heart failure after treatment for large B-cell lymphoma in Sweden during 2007-2022

IF7.1

2026-02-060

OAAI

Temporal trends in relative survival of diffuse large B-cell lymphoma in Sweden and Denmark in the era of targeted and cellular therapies

瑞典和丹麦在靶向疗法和细胞疗法时代弥漫性大B细胞淋巴瘤的相对生存率的时间趋势

BRITISH JOURNAL OF HAEMATOLOGY

IF3.8

2025-04-230

OAAI

Patient trajectories after diagnosis of diffuse large B-cell lymphoma-a multistate modelling approach to estimate the chance of lasting remission

BRITISH JOURNAL OF CANCER

IF6.8

2022-08-232

OA

Myocardial infarction in diffuse large B-cell lymphoma patients - a population-based matched cohort study

JOURNAL OF INTERNAL MEDICINE

IF9.2

2021-05-1810

OAAI

Incidence of relapsed/refractory diffuse large B-cell lymphoma (DLBCL) including CNS relapse in a population-based cohort of 4243 patients in Sweden

BLOOD CANCER JOURNAL

IF11.6

2021-01-0740

OAAI

ROR1 is Expressed in Diffuse Large B-Cell Lymphoma (DLBCL) and a Small Molecule Inhibitor of ROR1 (KAN0441571C) Induced Apoptosis of Lymphoma Cells

IF3.9

2020-06-2333

OAAI

Outcome and determinants of failure to complete primary R-CHOP treatment for reasons other than non-response among patients with diffuse large B-cell lymphoma

AMERICAN JOURNAL OF HEMATOLOGY

IF9.9

2020-04-0312

OAAI